Risk of hematologic malignancies following herpes zoster after COVID-19: a global cohort study.

Lu CL, Wang J, Ho CL, Wu YJ, Lu KC, Yang CC

Open source

DOI
10.3389/fmed.2025.1651614
Published
2025
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2025.1651614,
  title = {Risk of hematologic malignancies following herpes zoster after COVID-19: a global cohort study.},
  author = {Lu CL and Wang J and Ho CL and Wu YJ and Lu KC and Yang CC},
  year = {2025},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2025.1651614},
  url = {https://doi.org/10.3389/fmed.2025.1651614}
}

RIS

TY  - JOUR
TI  - Risk of hematologic malignancies following herpes zoster after COVID-19: a global cohort study.
AU  - Lu CL
AU  - Wang J
AU  - Ho CL
AU  - Wu YJ
AU  - Lu KC
AU  - Yang CC
PY  - 2025
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2025.1651614
UR  - https://doi.org/10.3389/fmed.2025.1651614
ER  - 

APA

CL, L., J, W., CL, H., YJ, W., KC, L., & CC, Y. (2025). Risk of hematologic malignancies following herpes zoster after COVID-19: a global cohort study.. Frontiers in medicine. https://doi.org/10.3389/fmed.2025.1651614

Source records